Surrogacy Market Analysis

Surrogacy Market Analysis

Surrogacy market from the Intrauterine insemination (IUI) technology is anticipated to register a 24% CAGR between 2023 to 2032. IUI, or donor insemination, is a process where healthy sperm is placed into the uterus to get closer to the egg, increasing the chances of fertilization. This technology is gaining traction among women in their early 30s, given its success rate of between 20-25%. Additionally, the IUI procedure is minimally invasive and cost-effective in comparison to other surrogacy treatments. Considering these advantages demonstrated by the technology, the adoption of IUI for surrogacy procedures is likely to increase over the forthcoming years.
 

Surrogacy market from the 40-42 years age group is projected to be worth over USD 13.5 billion by 2032. Rising number of working women between 40 to 42 years of age has led to increased stress levels, asserting a significant impact on reproduction ability. Working women are also becoming increasingly aware of procedures such as in-vitro fertilization (IVF), which enables them to conceive a pregnancy. Since women over 40 generally face irregular menstrual cycles which reduces their chances of conceiving naturally, the adoption of surrogacy procedures is expected to increase among this age group.
 

Surrogacy market from the hospitals service provider segment is expected to record over 24% CAGR from 2023 to 2032. This can be attributed to the growing infrastructural development of healthcare organizations. The increased integration of advanced surrogacy technologies such as Intrauterine insemination (IUI) is also shifting the preference of patients toward hospitals. Moreover, hospitals often employ surrogacy specialists that offer effective fertility treatment at a higher success rate, further encouraging patients to opt for surrogacy procedures in hospital settings.
 

Europe surrogacy market is projected to be valued at USD 61 billion by 2032. Improved healthcare infrastructure has increased the adoption of novel technology-based surrogacy procedures in the region. The European Union (EU) has also implemented various health policies, such as the EU4Health program which was adopted in March 2021 and valued at USD 5.12 billion (€5.1 billion), to promote investment and innovation in healthcare. The growing acceptance of the procedure, in addition to favorable regulatory policies, will fuel regional surrogacy industry forecasts.